Searched for
INDIAN DRUGMAKERS REGULATIONS
Punjab drug body finds critical lapses at Jackson Laboratories' manufacturing facility in AmritsarThe Punjab FDA has taken decisive action by revoking the manufacturing licence of Jackson Laboratories in Amritsar due to severe regulatory...- Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...
- School assembly news headlines for June 16: Top national, international, business, sports update and thought of the dayIndia and Slovakia elevate ties to a comprehensive partnership. A rival tutor accuses Khan Sir of murder. Delhi census Phase 1 records over...
- Drug companies directed to step up vigil on adverse reactionsIndia's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...
- U.S. drug regulator flags data integrity, maintenance lapses at Dabur India plantThe U.S. FDA has identified significant data integrity and manufacturing lapses at a Dabur India plant following a January inspection. Find...
- Eli Lilly halts India obesity awareness campaign after regulatory scrutiny, seeks rules clarityEli Lilly halted its obesity awareness campaign in India. The nation's drug regulator cautioned the company about potential violations. The...
- Govt's ammonia rule to hurt pharma cos as directive restricts sale of surplus to fertiliser firmsIndia’s pharmaceutical industry faces a potential raw material crunch after the government restricted surplus ammonia supply to fertiliser ...
- Weight-loss drug craze for Ozempic, Mounjaro surges in India amid safety concernsIn India, appetite for weight-loss drugs is on the rise, with consumers increasingly turning to injectables such as Mounjaro and Ozempic fo...
- Dr Reddy's gets nod to roll out generic oral semaglutide drug"The formulation was clinically evaluated in a head-to-head comparative study conducted in India, which established the non-inferiority to ...
- Iran war impact: Essential drugs may cost up to 5% more, for nowThe immediate net consumer impact could be 3-5% higher prices, or roughly similar to what consumers paid before the late-September cuts in ...
- Novo Nordisk’s weight-loss drug patent loss sparks a ‘gold rush’ for generic drugmakersIndia's weight-loss drug market is seeing a major shift. Generic versions of Novo Nordisk's semaglutide are now available at lower prices. ...
- India flags testing lapses at pharma firms after cough syrups deathsIndia's drug regulator revealed serious lapses in pharmaceutical firms failing to test medicinal ingredients, following the deaths of 17 ch...
- Indian regulator says 36% of inspected drug-making units had to be shutIndia's drug regulator has ordered the closure of over 36% of its 400 drug manufacturing units since last year due to concerns over sub-sta...
- India to mandate annual audit of pharma suppliers by drugmakersIndia is set to make it mandatory for drugmakers to audit their raw material suppliers at least once a year, following concerns over the sa...
- Indian drug regulator seen as corrupt: Roger Bate'There is a growing perception in the US that India’s drug regulator is unwilling to monitor the quality of drugs manufactured by the local...
- India wants USFDA chief to treat clinical volunteers on par with US counterpartsIndia's drug regulator may urge USFDA chief to ensure that drugmakers from US conducting clinical trials treat the volunteers on internatio...
- MNC may need govt nod to buy local pharma firmMultinationals may have to move buyout proposals through FIPB, allowing the govt to understand the firm's rationale for buying a local firm.
- Foreign cos asked to give price details of imported drugsThe country’s drug price regulator has asked for pricing details of drugs imported by some foreign drugmakers to find if they take advantag...
- Trouble ahead as US hints at tighter norms for genericsA top official with the US drugs regulator has hinted at tighter regulation for generic drugs, a move that could spell trouble for the Indi...
- No antidote to stop copies of patented drugs: Health minHealth ministry says not equipped with technical expertise to stop domestic pharmaceutical cos from copying patented drugs.
Load More
